Psychopharmacologia

, Volume 19, Issue 2, pp 114–127 | Cite as

L-Tryptophane and sleep

  • Ernest Hartmann
  • Richard Chung
  • Ching-Piao Chien
Human Pharmacology

Abstract

L-Tryptophane, an essential amino acid and a precursor of serotonin, is shown to have definite effects on human sleep. In normal subjects it reduces sleep latency and slightly increases sleep length without altering the qualitative characteristics of polygraphically recorded sleep. In a double-blind study of 24 hospitalized insomniac patients, doses of 4 g or 5 g of L-tryptophane significantly increased sleep time, reduced sleep latency, and reduced the number of awakenings.

Key -Words

Sleep Tryptophane Serotonin Insomnia Hypnogenic Medication 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Davidson, S., Meiklejohn, A. P. (eds.): Human Nutrition and Dietetics, p. 83. Edinburgh: Livingston, Ltd. 1963.Google Scholar
  2. Delorme, F., Jeannerod, M., Jouvet, M.: Effects remarquables de la réserpine sur l'activité EEG phasique ponto-géniculo-occipitale. C.R. Soc. Biol. (Paris) 159, 900–903 (1965).Google Scholar
  3. Dement, W., Kleitman, N.: Cyclic variations in EEG during sleep and their relation to eye movements, body motility and dreaming. Electroenceph. clin. Neurophysiol. 9, 673–690 (1957).CrossRefGoogle Scholar
  4. Ferguson, J., Cohen, H., Henriksen, S., McGarr, K., Mitchell, G., Hoyt, G., Barchas, J., Dement, W.: The effect of chronic administration of PCPA on sleep in the cat, presented to the Association for the Psychophysiological Study of Sleep, Boston, Mass., March 1969. Abstract: Psychophysiology 6, 220–221 (1969).Google Scholar
  5. Fieve, R. R.: Multiple measurements of behavior and metabolism in interdisciplinary research, presented at the one hundred twenty-third meeting of the American Psychiatric Association, Detroit, May 8–12, 1967.Google Scholar
  6. Gullino, P., Winitz, M., Birnbaum, S., Cornfield, J., Otey, M., Greenstein, J.: Studies on the metabolism of amino acids and related compounds in vivo. I. Toxicity of essential amino acids, individually and in mixtures, and the protective effect of L-arginine. Arch. Biochem. 64, 319–332 (1956).PubMedGoogle Scholar
  7. Hartmann, E.: The biology of dreaming. Springfield, Ill.: Ch. C. Thomas 1967a.Google Scholar
  8. —: The effect of L-tryptophane on the sleep-dream cycle in man. Psychonom. Sci. 8, 479–480 (1967b).Google Scholar
  9. —: The sleep-dream cycle and brain serotonin. Psychonom. Sci. 8, 295–296 (1967c).Google Scholar
  10. —: Adaptation to the sleep laboratory and placebo effect, presented to the Association for the Psychophysiological Study of Sleep, Santa Monica, California, April 1967. Abstract: Psychophysiology 4, 388 (1968a).Google Scholar
  11. —: The effect of LSD and L-tryptophane on the sleep-dream cycle in the rat. Presented to the Association for the Psychophysiological Study of Sleep, Santa Monica, California, April 1967. Abstract: Psychophysiology 4, 390 (1968b).Google Scholar
  12. —: On the pharmacology of dreaming sleep (the D-state). J. nerv. ment. Dis. 146, 165–173 (1968 c).PubMedGoogle Scholar
  13. —: Pharmacological studies of sleep and dreaming: Chemical and clinical relationships. Biol. Psychiat. 1, 243–258 (1969).PubMedGoogle Scholar
  14. —: The D-state and norepinephrine-dependent systems. In: E. L. Hartmann (ed.): Sleep and dreaming. Boston: Little, Brown & Co. 1970.Google Scholar
  15. Jouvet, M.: Telencephalic and rhombencephalic sleep in the cat. In: G. E. W. Wolstenholme and M. O'Connor (eds.): Ciba Foundation Symposium on the Nature of Sleep. Boston: Little, Brown & Co. 1960.Google Scholar
  16. Jouvet, M.: Mechanisms of the states of sleep: A neuropharmacological approach. Res. Publ. Ass. nerv. ment. Dis. 45, 86–126 (1967a).Google Scholar
  17. —: Biogenic amines and the states of sleep. Science 163, 32–41 (1968).Google Scholar
  18. —: Renault, J.: (Long-lasting insomnia after lesions of the raphe nuclei in the cat.) Insomnie persistante apres lesions des nouyaux du raphe chez le chat. C.R. Soc. Biol. (Paris) 160, 1461–1465 (1966).Google Scholar
  19. - Bobillier, F., Delorme, J. L., Froment, J., Mouret, J., Pujol, J., Renault, J.: Is serotonin (S) a sleep inducing “neuro modulator ?” Presented to the Association for the Psychophysiological Study of Sleep, Santa Monica, California, April 1967b.Google Scholar
  20. Kales, A., Malmstrom, E. J., Scharf, M. B., Rubin, R. T.: Psychophysiological and biochemical changes: Following use and withdrawal of hypnotics. In: A. Kales (ed.): Sleep physiology and pathology: A Symposium. Philadelphia: J. P. Lippincott 1969.Google Scholar
  21. King, E. J., Sperry, W. (eds.): Biochemists handbook, p. 1108. Princeton: Van Nostrand 1961.Google Scholar
  22. Koe, B. K., Weissman, A.: p-Chlorophenylalanine: A specific depletor of brain serotonin. J. Pharmacol. exp. Ther. 154, 499–516 (1966).PubMedGoogle Scholar
  23. Koella, W. P., Czicman, J.: Mechanism of the EEG-synchronizing action of serotonin. Amer. J. Physiol. 204, 873–880 (1963).PubMedGoogle Scholar
  24. —, Feldstein, A., Czicman, J.: The effect of para-chlorophenylalanine on the sleep of cats. Electroenceph. clin. Neurophysiol. 25, 481–490 (1968).CrossRefPubMedGoogle Scholar
  25. Kopin, I.: Personal communication to the author.Google Scholar
  26. Kupfer, D. J., Wyatt, R. J., Snyder, F.: Comparison between electroencephalographic and systematic nursing observations of sleep in psychiatric patients. J. nerv. ment. Dis. (in press) (1970).Google Scholar
  27. Lauer, J. W., Inskip, W. M., Bernsohn, J., Zeller, E. A.: Observations on schizophrenic patients after iproniazed and tryptophan. Arch. Neurol. Psychiat. 80, 122 (1958).Google Scholar
  28. Moir, A. T. B., Eccleston, D.: The effect of precursor loading in the cerebral metabolism of 5-hydroxyindoles. J. Neurochem. 15, 1093–1108 (1968).PubMedGoogle Scholar
  29. Mouret, J., Bobillier, P., Jouvet, M.: (Effects of parachlorophenylalanine on sleep in the rat.) Effets de la parachlorophenylalanine sur le Sommeil du rat. C.R. Soc. Biol. (Paris) 161, 1600–1603 (1967).Google Scholar
  30. Oates, J. A., Sjoerdsma, A.: Neurologic effects of tryptophane in patients receiving a monoamine oxidase inhibitor. Neurology (Minneap.) 10, 107 (1960).Google Scholar
  31. Oswald, I.: Drugs and sleep. Pharmacol. Rev. 20, 273–303 (1968).PubMedGoogle Scholar
  32. —, Ashcroft, G. W., Berger, R. J., Eccleston, D., Evans, J., Thacore, V. R.: Some experiments in the chemistry of normal sleep. Brit. J. Psychiat. 112, 391–399 (1966).PubMedGoogle Scholar
  33. Smith, B., Prockop, D. J.: Central-nervous-system effects of ingestion of L-tryptophane by normal subjects. New. Engl. J. Med. 267, 1338–1341 (1962).PubMedGoogle Scholar
  34. Williams, H. L., Lester, B. K., Coulter, J. D.: Monoamines and the EEG stages of sleep, presented to the Association for the Psychophysiological Study of Sleep, Denver, Colorado, March 1968.Google Scholar

Copyright information

© Springer-Verlag 1971

Authors and Affiliations

  • Ernest Hartmann
    • 1
  • Richard Chung
    • 1
  • Ching-Piao Chien
    • 1
  1. 1.Department of PsychiatryTufts University School of Medicine Boston State HospitalUSA

Personalised recommendations